OmnEcoil Instruments Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 4

OmnEcoil Instruments General Information


Developer of a novel device designed to offer prostate cancer detection and tissue sampling. The company's device avoids the traditional ultrasound-guided prostate biopsy, enabling health care providers to offer a more efficient and accurate diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 4640 Southwest Macadam Avenue
  • Suite 200D
  • Portland, OR 97239
  • United States

OmnEcoil Instruments Timeline

Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OmnEcoil Instruments Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 04-Jan-2018 Completed Generating Revenue
3. Grant 01-Jan-2018 00000 Completed Generating Revenue
2. Grant Completed Startup
1. Accelerator/Incubator Completed Startup
To view OmnEcoil Instruments’s complete valuation and funding history, request access »

OmnEcoil Instruments Executive Team (2)

Name Title Board Seat Contact Info
Fergus Coakley Founder, Inventor & Advisor
Robert DuFresne Jr. Chief Executive Officer
To view OmnEcoil Instruments’s complete executive team members history, request access »

OmnEcoil Instruments Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alignment Ventures Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Oregon Nanoscience and Microtechnologies Institute University 000 0000 000000 0
OTRADI Bioscience Incubator Accelerator/Incubator 000 0000 000000 0
To view OmnEcoil Instruments’s complete investors history, request access »